4Andrew Godkin,Miles Davenport,Adrian VS.Molecular analysis of HLA class Ⅱ associations with hepatitis B virus clearance and vaccine nonresponsiveness.Hepatology,2005,41 (6):1383-1390. 被引量：1
5Lin HH,Liao HW,Lin SK,et al.HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.Vaccine,2008,26 (27/28):3414-3420. 被引量：1
10Marie VW,Pierre VD,Roman C,et al.Hepatitis A/B vaccination of adults over 40 years old:Comparison of three vaccine regimens and effect of influencing factors.Vaccine,2006,24 (26):5509-5515. 被引量：1
4Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
8Nelson PK, Mathers BM, Cowie B, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews[ J]. Lancet,2011,378 (9791) :571-583. 被引量：1
9Programme HA. Guidance on Prevention of Viral Hepatitis B and c Among People Who Inject Drugs [ J ]. World Health Organization, 2012 : 1-52. 被引量：1
10Cui Y, Jia J. Update on epidemiology of hepatitis B and C in China [ J ]. J Gastroenterol Hepatolo, 2013,28 Suppl 1 : S7 -10. 被引量：1
